U.S. market Closed. Opens in 15 hours 34 minutes

ANRO | Alto Neuroscience, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
RevenueN/AN/A210.00K
Cost of Revenue373.00K342.00K145.00K
Gross Profit-373.00K-342.00K65.00K
Operating Expenses37.44M28.85M12.12M
Selling, General & Admin7.14M5.16M3.75M
Research & Development30.29M23.69M8.37M
Other Operating ExpensesN/AN/AN/A
Operating Income-37.81M-29.19M-12.06M
Other Expenses / Income1.50M1.48M2.87M
Before Tax Income-36.30M-27.71M-9.19M
Income Tax ExpensesN/AN/AN/A
Net Income-36.30M-27.71M-9.19M
Interest Expenses1.37MN/AN/A
Basic Shares Outstanding26.88M25.57M25.57M
Diluted Shares Outstanding26.88M25.57M25.57M
EBITDA-37.44M-28.85M-11.91M
EBITDA Margin0.00%0.00%-5,671.90%
EBIT-34.94M-27.71M-9.19M
EBIT Margin0.00%0.00%-4,374.76%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙